CMS proposes deeper 340B drug payment cuts for hospitals, reshaping outpatient cancer economics, consolidation incentives, and patient cost-sharing. The Centers for Medicare & Medicaid Services (CMS) ...
CMS proposes paying 340B-acquired drugs at ASP minus 33.4% starting CY 2027, replacing ASP plus 6%, based on survey findings that acquisition costs are well below ASP. Projected 2027 impact includes ...
CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull ...
Opinion
6dOpinion
Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs
Congress established the Drug Discount Program to help providers stretch scarce resources and expand care for low-income and uninsured patients.
Between the megabill’s July 2025 enactment and March 2026 (the last month with data on all states): These participation declines began before some of the major changes from H.R. 1 were fully in effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results